Literature DB >> 7983655

Fibroblast function in psoriatic arthritis. II. Increased expression of beta platelet derived growth factor receptors and increased production of growth factor and cytokines.

L R Espinoza1, C G Espinoza, M L Cuéllar, E Scopelitis, L H Silveira, G R Grotendorst.   

Abstract

OBJECTIVE: The main objective was to investigate the expression of platelet derived growth factor (PDGF) receptors, and production of growth factors and cytokines from psoriatic skin and synovium derived fibroblasts.
METHODS: Fibroblast cultures were established from normal and psoriatic skin and synovium. Confluent cultures of fibroblasts were used for a receptor binding assay for PDGF, and then extracts were run on Western blot. The amount of immunoreactive A and B chain peptides present was determined with specific A or B chain antisera. Production of interleukin 1 beta and PDGF-beta was accomplished by neutralization with the use of commercially available antisera. A functional assay was used to measure transforming growth factor-beta (TGF-beta).
RESULTS: There was an increased expression of the beta PDGF receptor in the psoriatic fibroblasts. Interleukin 1 beta and PDGF-beta production by psoriatic fibroblasts was also increased. However, TGF-beta production was similar in normal and psoriatic fibroblasts.
CONCLUSION: Our data demonstrate an increased expression of beta PDGF receptor, and production of IL-1 beta and PDGF by psoriatic fibroblasts. The findings provide further support for an active role of this cell line in the pathogenesis of psoriasis and psoriatic arthritis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7983655

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  8 in total

Review 1.  The History of Psoriatic Arthritis (PsA): From Moll and Wright to Pathway-Specific Therapy.

Authors:  Luis R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2018-08-09       Impact factor: 4.592

Review 2.  Pathways of cell activation in spondyloarthropathies.

Authors:  U Fearon; D J Veale
Journal:  Curr Rheumatol Rep       Date:  2001-10       Impact factor: 4.592

Review 3.  Traditional and newer therapeutic options for psoriatic arthritis: an evidence-based review.

Authors:  Dafna D Gladman
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 4.  Bedside to bench: defining the immunopathogenesis of psoriatic arthritis.

Authors:  Arlene Bravo; Arthur Kavanaugh
Journal:  Nat Rev Rheumatol       Date:  2019-09-04       Impact factor: 20.543

5.  The Th17/IL-23 Axis and Natural Immunity in Psoriatic Arthritis.

Authors:  Shinji Maeda; Yoshihito Hayami; Taio Naniwa; Ryuzo Ueda
Journal:  Int J Rheumatol       Date:  2012-04-01

6.  Functional role of IL-22 in psoriatic arthritis.

Authors:  Anupam Mitra; Smriti K Raychaudhuri; Siba P Raychaudhuri
Journal:  Arthritis Res Ther       Date:  2012-03-14       Impact factor: 5.156

7.  Infliximab (Remicade) in the treatment of psoriatic arthritis.

Authors:  Philip Mease
Journal:  Ther Clin Risk Manag       Date:  2006-12       Impact factor: 2.423

Review 8.  Bone-immune cell crosstalk: bone diseases.

Authors:  Giorgio Mori; Patrizia D'Amelio; Roberta Faccio; Giacomina Brunetti
Journal:  J Immunol Res       Date:  2015-04-27       Impact factor: 4.818

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.